Security
Health In Tech, Inc. Class A Common Stock · HIT
HITNASDAQCommon stockCurrentCIK 2019505Updated Oct 4, 2026
HIT price & chart
Loading TradingView…
NASDAQ:HIT on TradingView ↗About the company
Health In Tech, Inc. (Nasdaq: HIT) is an AI-enabled InsurTech platform company, which offers a marketplace that aims to improve processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, managing general underwriters ("MGUs") and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.
In the news
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance ↗
Recent filings
PRE 14A filing
Regulation FD Disclosure
Items 7.01, 9.01
SCHEDULE 13G - filed by LYTTON LAURENCE W regarding Health In Tech, Inc.
4 filing
4 filing
Show 5 more recent filings
144 filing
S-3 filing
4 filing
4 filing
Regulation FD Disclosure
Items 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 23,089,961Source | 15,768,489Source | 11,503,292Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,669,754Source | 7,849,248Source | 2,416,350Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 756,288Source | 1,647,103Source | 2,235,666Source |
| Assets, CurrentUSD | 16,160,976Source | 10,783,764Source | 6,859,267Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,280,148Source | 787,161Source | 264,382Source |
| Operating Lease, Right-of-Use AssetUSD | 139,940Source | 206,269Source | 266,641Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 5,977,896Source | 2,599,461Source | 5,410,066Source |
| Stockholders’ equity: | |||
| Additional Paid in CapitalUSD | — | 9,173,017Source | 2,770,538Source |
| Retained Earnings (Accumulated Deficit)USD | 5,220,238Source | 3,941,396Source | 3,270,919Source |
| Stockholders' Equity Attributable to ParentUSD | 17,112,065Source | — | — |
| Additional Paid in Capital, Common StockUSD | 11,834,121Source | — | — |
| Liabilities and EquityUSD | 23,089,961Source | 15,768,489Source | 11,503,292Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 5,156,604Source | 2,130,974Source | 4,781,393Source |
| Operating Lease, Liability, CurrentUSD | 76,195Source | 66,881Source | 58,482Source |
| Operating Lease, Liability, NoncurrentUSD | 63,617Source | 139,811Source | 206,693Source |
| Deferred Income Tax Liabilities, NetUSD | 757,675Source | 328,676Source | 421,980Source |
| Additional Financial Items | |||
| Deferred Tax Liabilities, NetUSD | 757,675Source | 376,261Source | 421,980Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | 670,477Source | 3,957,914Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 900,577Source | 541,141Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,570,419Source | 468,489Source | — |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | -907,049Source | -586,685Source | 1,279,324Source |
| Deferred Income Tax Expense (Benefit)USD | 428,999Source | -93,304Source | 133,980Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 3,133,813Source | 2,176,209Source | 1,528,878Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -3,125,921Source | -836,755Source | -1,944,361Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -187,386Source | 4,093,444Source | 1,343,880Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 7,669,754Source | 7,849,248Source | 2,416,350Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | 2,052Source |
| Income Taxes Paid, NetUSD | 830,726Source | 558,521Source | 479,209Source |
| Additional Financial Items | |||
| General and Administrative ExpenseUSD | 13,654,262Source | 8,477,407Source | 8,079,329Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | 670,477Source | 2,476,660Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,481,254Source |
| Income Tax Expense (Benefit)USD | 395,330Source | 218,523Source | 945,236Source |
| InterestExpenseNonoperatingUSD | — | 495,000Source | 2,052Source |
| Investment Income, InterestUSD | 409,922Source | 122,885Source | 40,857Source |
| Net Income (Loss) Attributable to ParentUSD | 1,278,842Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 1,481,254Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | 670,477Source | 2,476,660Source |
| Nonoperating Income (Expense)USD | 145,734Source | -100,904Source | 38,805Source |
| Operating ExpensesUSD | 19,409,290Source | 14,449,563Source | 13,464,500Source |
| Proceeds from Issuance of Common StockUSD | — | 8,214,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 23,430Source | — | — |
| Provision for Loan, Lease, and Other LossesUSD | 634,982Source | 249,285Source | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 37,563,851Source | 19,590,763Source | 19,237,296Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total RevenueUSD | 33,327,511Source | 19,490,906Source | 19,151,502Source |
| Cost of Goods and Services Sold | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 1,674,172Source | 889,000Source | 3,421,896Source |
| Income Tax Expense (Benefit)USD | 395,330Source | 218,523Source | 945,236Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 1,481,254Source |
| Net Income (Loss) Attributable to ParentUSD | 1,278,842Source | — | — |
| Earnings Per Share, BasicUSD per share | 0.02Source | — | — |
| Earnings Per Share, DilutedUSD per share | 0.02Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 55,843,821Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 57,742,798Source | — | — |
| Interest Expense (non-operating)USD | — | 495,000Source | 2,052Source |
| Additional Financial Items | |||
| Current Income Tax Expense (Benefit)USD | -33,669Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | 541,141Source | 339,300Source |
| General and Administrative ExpenseUSD | 13,654,262Source | 8,477,407Source | 8,079,329Source |
| Gross ProfitUSD | 20,937,728Source | 15,439,467Source | 16,847,591Source |
| Income (Loss) Attributable to Parent, before TaxUSD | 1,674,172Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | 670,477Source | 2,476,660Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,481,254Source |
| Interest Income, OtherUSD | 64,000Source | 63,996Source | 15,999Source |
| Investment Income, InterestUSD | 409,922Source | 122,885Source | 40,857Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | 670,477Source | 2,476,660Source |
| Nonoperating Income (Expense)USD | 145,734Source | -100,904Source | 38,805Source |
| Operating ExpensesUSD | 19,409,290Source | 14,449,563Source | 13,464,500Source |
| Other ExpensesUSD | 377,587Source | — | — |
| Research and Development ExpenseUSD | 1,569,262Source | 2,813,899Source | 2,004,796Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 37,563,851Source | 19,590,763Source | 19,237,296Source |
| Selling and Marketing ExpenseUSD | 4,185,766Source | 3,158,257Source | 3,380,375Source |
Offerings
Registration 333-298758
Registration 333-296696
Registration 333-295321
Filing attachments
ea030726301ex99-1.htm · 8-K · 2026-09-30
Exhibit 99.1 Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market. STUART, Fla., September 30, 2026 /PRNewswire/ - Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company (“Health In Tech”…
Read attachment ↗ea030198401ex99-1.htm · 8-K · 2026-08-13
EX-99.1 2 ea030198401ex99-1.htm TRANSCRIPT Exhibit 99.1 Q2 2026 Earnings Conference Call August 13, 2026 5:00 PM ET Presenter Dial-In (US/Canada Toll Free): 1-866-250-8117 International Dial-In: 1-412-317-6011 Presenters are asked to please connect a minimum of 15 minutes prior to the conference start time. When the speakers are connected, the conference specialist will do a brief sound check for your line. You will also be asked to review the following items: verify conference title, …
Read attachment ↗ea030198101ex99-1.htm · 8-K · 2026-08-13
EX-99.1 2 ea030198101ex99-1.htm INVESTOR PRESENTATION Exhibit 99.1 An AI-Powered Marketplace Platform Helping SMBs Access Better Self-Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we," "our," or "us") solely for informational purposes. The information included herein in this presentation has not been independently verified. No representations, warranties or undertakings, express or impl…
Read attachment ↗ea030198001ex99-1.htm · 8-K · 2026-08-13
EX-99.1 2 ea030198001ex99-1.htm PRESS RELEASE DATED AUGUST 13, 2026 Exhibit 99.1 Health In Tech Reports Second Quarter 2026 Financial Results Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year Stuart, FL., August 13, 2026 /PRNewswire/ - Health In Tech, Inc. (Nasdaq: HIT) (“Health In Tech” or the “Company”), an AI-enabled InsurTech platform company, today announced its unaudited fin…
Read attachment ↗ea030181901ex4-1.htm · 10-Q · 2026-08-13
Exhibit 4.1 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEM…
Read attachment ↗ea029587301ex4-4.htm · S-3/A · 2026-06-26
Exhibit 4.4 HEALTH IN TECH, INC., as Issuer And ●, as Trustee INDENTURE Dated as of ● Senior Debt Securities CROSS REFERENCE SHEET1 Between Provisions of the Trust Indenture Act of 1939 and the Indenture to be dated as of _________, 20____ between HEALTH IN TECH, INC., as Issuer, and ___________________, as Trustee: Section of the Act Section of Indenture 310(a)(1) and (2) 5.08 310(a)(3) and (4) Inapplicable 310(b) 5.09(a), (b) …
Read attachment ↗